The clonoSEQ® Watch Registry

Clinical trial NCT04545333 · TERMINATED

Trial details

NCT number: NCT04545333
Sponsor: Adaptive Biotechnologies
Status: TERMINATED
Study type: OBSERVATIONAL

Acute Lymphoblastic Leukemia, Adult B-Cell Chronic Lymphocytic Leukemia Multiple Myeloma Non-hodgkin Lymphoma

Start date: 2020-10-13
Primary completion: 2023-10-01
Enrollment: 465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.